In this online, self-learning activity:
Parkinson’s disease (PD), a central nervous system disease of the autonomic and basal ganglia, neocortex, and spinal cord, is thought to affect about one million people in the United States. Its etiology is thought to include a confluence of factors including age, genetic predisposition, comorbid disease states (e.g., Gaucher’s disease), and environmental factor dynamics. Present in 1% of people over age 65 and 2.5% of those older than 80, its symptoms are the direct result of dopaminergic neuronal degradation along the nigrostriatal tract and include bradykinesia, resting tremor, muscle rigidity, and gait disturbance.
The following healthcare professionals: neurologists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in neurology; and any other healthcare professionals with an interest in or who clinically encounter patients with PD.
This program is supported by an educational grant from Acorda.
Release Date: March 27, 2018 -- Expiration Date: March 27, 2020
Faculty: Natalie Diaz, MD
Faculty introduction, disclosures
Introduction content: cursory refresher and review of PD
Treatment of PD
By the end of the session the participant will be able to:
ACCME Activity #201226438ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Dr. Natalie Diaz, MD, Associate Professor in Neurology, David Geffen School of Medicine at UCLA, has received research support from Pfizer, Civitas, Chelsea, Adamas, SK Life.
Disclosures of Educational Planners: Charles Turck, PharmD has no relevant conflicts of interest to disclose.
Commercial Support Disclosure: This program is supported by an educational grant from Acorda
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.
Parkinson's disease: Highlights from the American Academy of Neurology 2017 Annual Meeting (AAN 2017)
Chronic inflammatory demyelinating polyneuropathy (CIDP): therapeutic updates, best practices, and emerging therapies
Multiple Sclerosis (MS) and Its Complications: Highlights from the American Academy of Neurology 2016 Annual Meeting (AAN 2016) : Take-Aways, Emerging Practice Changes, and Barriers to their Implementation